The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit

Sponsor

University of British Columbia (Other)

Overall Status

Withdrawn

CT.gov ID

NCT01612091

Collaborator

(none)

Enrollment

Location

Arms

Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The Mobile Messenger is a unified, portable and intelligent device that integrates information from multiple patient monitors, mechanical ventilators, infusion pumps and clinical information systems on a mobile platform. It will allow nurses, respiratory therapists and physicians to continuously monitor and coordinate care of critically ill patients. This study will use a participatory design process to guide the design of an integrated mobile device. Next, we will evaluate the proposed device in a simulated ICU setting.

Condition or Disease	Intervention/Treatment	Phase
Medical Device User-Computer Interface Critical Care Physiologic Monitoring	Device: Monitoring Messenger Device: Traditional tools	N/A

Detailed Description

There are a limited number of nurses, respiratory therapists and physicians in an ICU at a given time. To make decisions and plan therapies, these clinicians need to observe, assimilate and interpret a vast array of information originating from various devices located on the bedsides of multiple patients. Several shortcomings in existing technology limit their abilities: a) the fixed location of monitoring devices at the bedside; b) information overload from a multitude of devices, each with its own display; c) the lack of integration and interaction between these devices; d) the use of visually cumbersome displays, which were historically created for monitoring during anesthesia but never optimized for users in the ICU; and e) lack of context specific information (such as historical trends) to support patient data interpretation and clinical decision making.

This project proposes to address these challenges in ICU monitoring by developing a unified, portable, and intelligent device: the Monitoring Messenger. By integrating information from multiple monitoring devices, mechanical ventilators, infusion pumps and clinical information systems on a mobile device (tablet PC or smart phone); the Monitoring Messenger will allow nurses, respiratory therapists and physicians on or off-site, to continuously monitor critically ill patients, thereby increasing patient safety.

The proposed experiment will have two parts: Part I - Participatory design and Part II - Simulation Experiment.

In Part I - Participatory Design. Participatory design an inter-professional team of nurses, physicians, designers, engineers, and human factors experts will follow a user-centered design process to obtain the system requirements, and obtain feedback during the rapid prototyping phase of prototype development. While we expect the resulting prototype to be easy to use, support decision making, improve awareness of the patient's condition by health care providers and reduce mental workload, this methodology is not hypothesis driven.

Part II - Simulation Experiment. In simulated ICU scenarios, the critical care physicians, nurses, and respiratory therapists will prioritize the care of critically ill patients. We expect them to do so more accurately with the use of Monitoring Messenger than with their regular tool (monitors, paper records etc). A potential outcome would be a decrease in mental workload as well as an increase in situational awareness.

Study Design

Study Type:

Interventional

Actual Enrollment :

0 participants

Allocation:

Randomized

Intervention Model:

Crossover Assignment

Masking:

None (Open Label)

Primary Purpose:

Basic Science

Official Title:

The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit

Study Start Date :

Nov 1, 2013

Anticipated Primary Completion Date :

Jan 1, 2017

Anticipated Study Completion Date :

Jan 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Monitoring Messenger	Device: Monitoring Messenger Monitoring Messenger prototype device
Active Comparator: Control Traditional tools (monitors, paper records)	Device: Traditional tools Paper based records, screenshots of monitors and therapy devices

Arm

Intervention/Treatment

Experimental: Monitoring Messenger

Device: Monitoring Messenger

Monitoring Messenger prototype device

Active Comparator: Control

Traditional tools (monitors, paper records)

Device: Traditional tools

Paper based records, screenshots of monitors and therapy devices

Outcome Measures

Primary Outcome Measures

Accuracy of priority assignment in triaging task [Up to 1 hour]
Accuracy will be measured by matching of the participants triage priority ranking with the previously defined expert ranking.

Secondary Outcome Measures

Requirements for design of the mobile device [Up to 2 hours]
Information requirements for tasks, task frequencies, perceived challenges and potential suggestions to improve their current work environment using a mobile monitoring and messaging device

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Staff pediatric critical care physicians, pediatric critical care fellow physicians, registered pediatric nurses and respiratory therapists will be eligible to participate in this study
Subjects willing to provide informed consent

Exclusion Criteria:

Inability/failure to provide informed consent.
Nursing students and resident physicians are not eligible
For Part II - Simulation Experiment only: Failure to complete the post-training quiz more than twice.
Evaluation will be immediately discontinued at request of subject at any point during the study.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	BC Children's Hospital	Vancouver	British Columbia	Canada	V6H 3V4

Sponsors and Collaborators

University of British Columbia

Investigators

Principal Investigator: Mark Ansermino, MBBCh, FRCPC, The University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.

Responsible Party:

Mark Ansermino, Principle Investigator, University of British Columbia

ClinicalTrials.gov Identifier:

NCT01612091

Other Study ID Numbers:

H12-01270

First Posted:

Jun 5, 2012

Last Update Posted:

Oct 26, 2017

Last Verified:

Oct 1, 2017

Keywords provided by Mark Ansermino, Principle Investigator, University of British Columbia

Study Results

No Results Posted as of Oct 26, 2017